Abstract Submission

Abstract Submission has been closed on July 17, 2023.
For submitting a late-breaking abstract, please refer to the Late Breaking Abstract Submission page here.

On behalf of the Organizing Committee of the 8th World Intracranial
Hemorrhage Conference, we would like to thank you for submitting your work
as an abstract.

The online submission and evaluation process is administered by Kenes M+, the
Conference Organizing Secretariat.

The Extended Abstract Submission has been closed on July 17, 2023 23:59 (GMT -4). 


*To submit your abstract, you will first be led to the abstract submission payment page to complete payment of the abstract submission charge of 20 USD per abstract. The link to the abstract submission page will be provided after submitting payment. In case of any difficulties, please contact the Conference Organizing Secretariat at mrodic@kenes.com.

Please take a moment to read the guidelines below before submitting your abstract:


  • Each abstract submitter should pay the abstract submission fee of 20 USD per abstract to be able to submit the abstract, which will be sent to review.
  • All abstracts must be written in English.
  • All abstracts must be submitted online through the abstract submission system by the deadline given above. Abstracts that are sent via e-mail will not be included in the abstract review process.
  • Please do NOT submit multiple copies of the same abstract.
  • Use acronyms only when necessary and define all abbreviations and concepts in your abstract at first use.
  • The submitting and presenting authors are required to ensure that all co-authors are aware of the content of the abstract before submission.
  • Always make sure to check the final abstract with the system's preview function before submission and edit or replace as necessary. It is the authors' responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
  • Only the accepted abstracts of presenting authors who have completed their registrations and paid their registration fees by the abstract presenters registration deadline of August 14, 2023 will be included in the Scientific Program and conference abstract e-book and published in the Cerebrovascular Diseases journal.
  • Since there will be no editing process on the abstracts, the authors are required to avoid any typing errors, misordering of the authors, wrong spelling/writing about the institutions, etc.



STEP 1- Presentation Options

  • Topic/Sub-Topic: A main topic that is relevant for your abstract must be selected during Step 1 of the submission process. The Scientific Committee reserves the right to change the topics during the abstract review process.
    The topics for WICH 2023 are listed on the Conference website. Please CLICK HERE for reviewing topics before proceeding with the submission process.
  • Presentation type: Please choose one of the following:

- Oral presentation
- Poster presentation

The Scientific Committee reserves the right to change the presentation type according to the requirements of the scientific program. The decision of the Committee is final.

STEP 2 - Institution Information

  • The institution(s) of the authors should be indicated fully with the “department” and “institution” names while avoiding any abbreviations such as Dept., Univ., Inst., Hosp., etc.
  • The department and institution details, city and country should be written with lower case while the initials of each word in capitals.
  • Please make sure to include the City and Country information at the end for each institution.
  • Enter each affiliation only once:e., if there are 5 authors and 3 of whom are from same affiliation and 2 of whom are from another, you will have 2 institutions, NOT 5. However, if there are 2 or more departments at the same institution represented, they should be entered separately.
  • If any of the authors have more than one affiliation, enter both affiliations in a compounded style as one affiliation:e., if there are 5 authors and 2 of whom are from same affiliation (Institute A), 2 of whom are from another (Institute B), and 1 of whom is from both affiliations (Institutes A and B), you will have 3 institutions, NOT 5 or NOT 2. (First institution: Institute A, second one: Institute B and the third one: Institute A & Institute B).

STEP 3 - Author Information

  • First, middle and last names of all the authors must be fully indicated correctly and in the right order. Please pay attention to matching the institutions from the dropdown menu to the right authors, and make sure that you select the “presenting author” correctly.

STEP 4 - Presenting Author Information

  • Please enter the presenting author’s contact information correctly.

It’s highly important for you to ensure that the e-mail address of presenting author is entered correctly, as all communication regarding the acceptance, any required adjustments, and scheduling will be sent to the presenting author via e-mail by the Conference Organizing Secretariat.

  • The presenting author will be required to register for the Conference in order to confirm acceptance of the abstract.

STEP 5 - Abstract Title

  • An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.
  • Abstract titles can contain a maximum of 100 characters.
  • Titles should not be written with all capitals.
  • Use only generic drug names. Brand, product or company names must not be used in the abstract title or text. WICH 2023 Organizing and Scientific Committees reserve the right to replace any brand name with a generic name.

STEP 6 - Abstract

  • Abstract Body: Abstract body should not exceed 2500 characters. The title of the abstract, authors, institutions and keywords are not included in this limit, and those should not be entered in this section.
  • Abstract body should consist of 4 sections given below:
    • Objectives: Clearly state the purpose of the abstract. Briefly describe the objectives of the study unless they are contained in the title.
    • Methods: Describe your selection of observations or experimental subjects clearly. Include a brief statement of methods if pertinent.
    • Results: Present your results in a logical sequence in text, table and illustrations. State findings in sufficient detail to support conclusions.
    • Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
  • Abstracts should not describe research in which the chemical identity or source of the reagent is proprietary or cannot be revealed.
  • Standard abbreviations may be used without definition. Non-standard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
  • Do not include the names or personal information of any patient participating in a study or trial.
  • Phrases such as “results will be discussed” or “data will be presented” shall not be used.
  • References, funding sources and acknowledgements should not be included in the abstract body.
  • Use only generic drug names. Brand, product or company names must not be used in the abstract title or text. WICH 2023 Organizing and Scientific Committees reserve the right to replace any brand name with a generic name.

STEP 7 - Keywords

  • Keywords should not be included in the abstract body but written in the section dedicated for keywords.
  • Minimum 1 keyword is required and maximum 6 keywords can be entered.
  • All keywords should be written in lower case and separated with comma (,).

STEP 8 - Additional Files

  • Images, tables, diagrams and graphs are accepted.

STEP 9 - Preview & Check

  • The submitting authors are required to preview the abstract at this step and confirm the preview at this step.
  • Any comments and/or additional information to be shared with the Scientific Committee can be submitted through the comment box.

STEP 10 - Submit to the Committee

  • If you have not completed all required sections of your abstract, you won’t see the submission button. Only after completing all required fields, the submission button will be enabled for you.

After Submission

  • When the submission process is finalized, you will see your abstract under the heading "Submitted Abstracts". If your abstract is not seen there, please kindly turn back and check the steps of your submission. Please be aware that the Scientific Committee will not receive "Not-Submitted Abstracts" and these therefore CANNOT be taken into consideration in the abstract review process.
  • Upon submitting of your abstract an e-mail including the "Abstract Number" and "Abstract Title" will be sent to the submitting author. Please make sure to save your username and password for future use. If you cannot remember your credentials, please get in contact with the Conference Organizing Secretariat at mrodic@kenes.com.
  • You can make edits on your abstract before submitting it to the Scientific Committee. After the submission is completed, no edits will be allowed on the system even if there is time until the deadline. In that case, if you have to make some edits on your abstract after submitting but before the submission deadline, please contact with the Conference Organizing Secretariat at (mrodic@kenes.com).


All submitted abstracts will be scored and passed through a review process after the submission closes. The notification letters about acceptance of the abstracts will be sent at the end of July 2023.


The presenting author(s) must be registered for the Conference latest by August 14, 2023, which is the registration deadline for abstract presenters.

The abstracts of unregistered presenting authors who do not complete registration (including payment) by this deadline will be removed from the final program and all conference publications. 


Thank you for submitting your work for consideration. Please contact us directly at mrodic@kenes.com, should you have any specific inquiries.


Newsletter Subscription

Don't miss a thing! Subscribe to our newsletters and be the first to know